- Country: Czech Republic
- Summary: Atc Group L04ab05 Medicinal Product with the Active Substance Certolizumab-Pegol
- CZT Ref No: 124413642
- Deadline: 25 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 1224000
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the fulfillment of the public contract is to ensure the continuous supplies of the ATC Group L04AB05 with the active substance Certolizumab-Pegol for 2 years.
Medicinal products and medical devices - Documents:
4a77202d11f10930de3b9eca3596dff6.vyzva.a.zadavaci.dokumentace.zip
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAtc Group L04ab05 Medicinal Product with the Active Substance Certolizumab-Pegol - Czech Republic Tender
The HOSPITAL OF THE PARDUBICE REGION, A.S., a Government sector organization in Czech Republic, has announced a new tender for Atc Group L04ab05 Medicinal Product with the Active Substance Certolizumab-Pegol. This tender is published on CzechRepublicTenders under CZT Ref No: 124413642 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-25.
The estimated tender value is CZK 1224000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
